The costs of alcohol, illegal drugs, and tobacco in Canada, 2002

Journal of Studies on Alcohol and Drugs

Volumn 68, Issue 6, 2007, Pages 886-895

  Rehm, Jürgen ^a,b,c,d   Gnam, William ^a,e   Popova, Svetlana ^a,c   Baliunas, Dolly ^a,c   Brochu, Serge ^a,f   Fischer, Benedikt ^a,g   Patra, Jayadeep ^a,c   Sarnocinska Hart, Anna ^a   Taylor, Benjamin ^a,c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b Institut fur Sucht und Gesundheitsforschung Zurich   (Switzerland)

^c UNIVERSITY OF TORONTO   (Canada)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e INSTITUTE FOR WORK AND HEALTH   (Canada)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

^g UNIVERSITY OF VICTORIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; ILLICIT DRUG;

ARTICLE; CANADA; CONTROLLED STUDY; CRIMINAL JUSTICE; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; LAW ENFORCEMENT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PASSIVE SMOKING; PREVALENCE; QUALITY OF LIFE; RISK ASSESSMENT; SUBSTANCE ABUSE; TOBACCO;

EID: 36348978010     PISSN: 19371888     EISSN: 19384114     Source Type: Journal    
DOI: 10.15288/jsad.2007.68.886     Document Type: Article

References (39)

1. AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), Primary Care, Washington, DC, 1995.
2. ANDERSON, P. AND BAUMBERG, B. Alcohol in Europe. A Report of the European Commission, London, England: Institute of Alcohol Studies, 2006.
3. ANDLIN-SOBOCKI, P. AND REHM, J. Cost of addiction in Europe. Europ. J. Neurol. 12 (Suppl. No. 1): 28-33, 2005.
4. BABOR, T., CAETANO, R., CASSWELL, S., EDWARDS, G., GIESBRECHT, N., GRAHAM, K., GRUBE, J., GRUENEWALD, P., HILL, L., HOLDER, H., HOMEL, R., ÖSTERBERG, E., REHM, J., ROOM, R., AND ROSSOW, I. (Eds.) Alcohol: No Ordinary Commodity. Research and Public Policy, New York: Oxford Univ. Press, 2003.
5. BALIUNAS, D., PATRA, J., REHM, J., POPOVA, S., TAYLOR, B., AND KAISERMAN, M. Smoking-attributable mortality in Canada 2002: Conclusions for prevention and policy. Chronic Dis. Can. 27: 152-164, 2007.
6. BROCHU, S., COUSINEAU, M., AND SUN, F. Crime Associated with Alcohol and Drugs Among Offenders in Ontario Provincial Prisons, Ottawa, Canada: Canadian Centre on Substance Abuse, 2005.
7. BÜECHI, M. AND MINDER, U. Swiss Drug Policy: Harm Reduction and Heroin-Supported Therapy, Vancouver, Canada: The Frasier Institute, 2001.
8. CANADIAN CENTRE ON SUBSTANCE ABUSE. Canadian Addiction Survey 2004: Microdata eGuide, Ottawa, Canada: Canadian Centre on Substance Abuse, 2004.
9. CANADIAN COORDINATING OFFICE FOR HEALTH TECHNOLOGY ASSESSMENT. Guidelines for the Economic Evaluation of Pharmaceuticals: Canada, 2nd Edition, Ottawa, Canada: Canadian Coordinating Office for Health Technology Assessment, 1997.
10. CHISHOLM, D., REHM, J., VAN OMMEREN, M., AND MONTEIRO, M. Reducing the global burden of hazardous alcohol use: A comparative cost-effectiveness analysis. J. Stud Alcohol 65: 782-793, 2004.
11. COLLINS, D.J. AND LAPSLEY, H.M. Estimating the Economic Costs of Drug Abuse in Australia. National Campaign Against Drug Abuse, Monograph Series No. 15, Canberra, Australia: Australian Government Publishing Service, 1991.
12. COLLINS, D.J. AND LAPSLEY, H.M. Counting the Cost: Estimates of the Social Costs of Drug Abuse in Australia in 1998-9. National Drug Strategy Monograph Series No. 49, Canberra, Australia: Commonwealth Department of Health and Ageing, 2002.
13. COLLINS, D., LAPSLEY, H., BROCHU, S., EASTON, B., PÉREZ-GÓMEZ, A., REHM, J., AND SINGLE, E. International Guidelines for the Estimation of the Avoidable Costs of Substance Abuse, Ottawa, Canada: Health Canada, 2006.
14. ENGLISH, D.R., HOLMAN, C.D.J., MILNE, E., WINTER, M.G., HULSE, G.K., CODDE, J.P., BOWER, C.I., CORTI, B., DE KLERK, N., KNUIMAN, M.W., KURINCZUK, J.J., LEWIN, G.F., AND RYAN, G.A. The Quantification of Drug Caused Morbidity and Mortality in Australia 1995, Canberra, Australia: Commonwealth Department of Human Services and Health, 1995.
15. EZZATI, M., LOPEZ, A.D., RODGERS, A., VANDER HOORN, S., MURRAY, C.J.L., AND THE COMPARATIVE RISK ASSESSMENT COLLABORATING GROUP. Selected major risk factors and global and regional burden of disease. Lancet 360: 1347-1360, 2002.
16. HARWOOD, H.J. Updating Estimates of the Economic Costs of Alcohol Abuse in the United States: Estimates, Update Methods, and Data, Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism, 2000.
17. HILL, A.B. The environment and disease: Association or causation? Proc. Royal Soc. Med. 58: 295-300, 1965.
18. KOOPMANSCHAP, M.A. AND RUTTEN, F.F. A practical guide for calculating indirect costs of disease. Phaimacoeconomics 10: 460-466, 1996.
19. PERNANEN, K., COUSINEAU, M.-M., BROCHU, S., AND SUN, F. Proportions of Crimes Associated with Alcohol and Other Drugs in Canada, Ottawa: Canadian Centre on Substance Abuse, 2002.
20. POPOVA, S., REHM, J., AND FISCHER, B. An overview of illegal opioid use and health services utilization in Canada. Publ. Hlth 120: 320-328, 2006a.
21. POPOVA, S., REHM, J., AND PATRA, J. Illegal drug-attributable mortality and potential years of life lost in Canada 2002: Implications for prevention and policy. Contemp. Drug Probl. 33: 343-366, 2006b.
22. RAMIREZ-JONVILLE, A. Toxicomanies: La politique de reduction des risques en France et en Espagne (Drug addiction: Harm reduction policies in France and Spain). Presse Med. 35: 1151-1161, 2006.
23. REHM, J., BALIUNAS, D., BROCHU, S., FISCHER, B., GNAM, W., PATRA, J., POPOVA, S., SARNOCINSKA-HART, A., AND TAYLOR, B. The Costs of Substance Abuse in Canada 2002, Ottawa, Canada: Canadian Centre on Substance Abuse, 2006a.
24. REHM, J., KLOTSCHE, J., AND PATRA, J. Comparative quantification of alcohol exposure as risk factor for global burden of disease. Int. J. Meth. Psychiat. Res. 16: 66-76, 2007.
25. REHM, J., PATRA, J., AND POPOVA, S. Alcohol-attributable mortality and potential years of life lost in Canada 2001: Implications for prevention and policy. Addiction 101: 373-384, 2006b.
26. REHM, J., SEMPOS, C.T., AND TREVISAN, M. Average volume of alcohol consumption, patterns of drinking and risk of coronary heart disease: A review. J. Cardiovasc. Risk 10: 15-20, 2003.
27. REHM, J., TAYLOR, B., PATRA, J., AND GMEL, G. Avoidable burden of disease: Conceptual and methodological issues in substance abuse epidemiology. Int. J. Meth. Psychiat. Res. 15: 191-211, 2006c.
28. ROTHMAN, K.J. AND GREENLAND, S. Causation and casual inference. In: ROTHMAN, K.J. AND GREENLAND, S. (Eds). Modern Epidemiolgy, 2nd Edition, Philadelphia, PA: Lippincott Williams & Wilkens, Philadelphia, PA: 1998, pp. 7-28.
29. SHIBUYA, K., CIECIERSKI, C., GUINDON, E., BETTCHER, D.W., EVANS, D.B., AND MURRAY, C.J.L. WHO Framework Convention on Tobacco Control: Development of an evidence based global public health treaty. Brit. Med. J. 327: 154-157, 2003.
30. SINGLE, E., COLLINS, D., EASTON, B., HARWOOD, H., LAPSLEY, H., KOPP, P., AND WILSON, E. International Guidelines for Estimating the Costs of Substance Abuse, 2nd Edition, Geneva, Switzerland, World Health Organization, 2003.
31. SINGLE, E., ROBSON, L., REHM, J., AND XIE, X. Morbidity and mortality attributable to alcohol, tobacco, and illicit drug use in Canada. Amer. J. Publ. Hlth 89: 385-390, 1999.
32. SINGLE, E., ROBSON, L., XIE, X., AND REHM, J. The Costs of Substance Abuse in Canada: Highlights of a Major Study of the Health, Social and Economic Costs Associated with the Use of Alcohol, Tobacco and Illicit Drugs, Ottawa, Canada: Canadian Centre on Substance Abuse, 1996.
33. SINGLE, E., ROBSON, L., XIE, X., AND REHM, J. The economic costs of alcohol, tobacco and illicit drugs in Canada, 1992. Addiction 93: 991-1006, 1998.
34. STATISTICS CANADA. The 2002 Canadian Community Health Survey, Cycle 1.2, Mental Health and Well-Being, Original Micro Data Documentation (Master Data File), 2002.
35. STATISTICS CANADA. Canadian Community Health Survey, Cycle 2.1, Public Use Microdata File (82M0013XCB), Ottawa, Canada: Statistics Canada, 2003.
36. TAYLOR, B. AND REHM, J. Moderate alcohol consumption and diseases of the gastrointestinal system: A review of pathophysiological processes. Digest. Dis. 23 (3-4): 177-180, 2005.
37. WALTER, S.D. The estimation and interpretation of attributable risk in health research. Biometrics 32: 829-849, 1976.
38. WALTER, S.D. Prevention of multifactorial disease. Amer. J. Epidemiol. 112: 409-416, 1980.
39. WORLD HEALTH ORGANIZATION. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10), 2nd Edition, Vols. 1 and 2, Geneva, Switzerland: World Health Organization, 2004.